Carrie A Karvonen-Gutierrez1, Huiyong Zheng2, Peter Mancuso3, Siobán D Harlow2. 1. Department of Epidemiology and ckarvone@umich.edu. 2. Department of Epidemiology and. 3. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor.
Abstract
BACKGROUND: Excess fat mass is a greater contributor to functional limitations than is reduced lean mass or the presence of obesity-related conditions. The impact of fat mass on physical functioning may be due to adipokines, adipose-derived proteins that have pro- or anti-inflammatory properties. METHODS: Serum samples from 1996 to 2003 that were assayed for leptin, adiponectin, and resistin were provided by 511 participants from the Michigan site of the Study of Women's Health Across the Nation. Physical functioning performance was assessed annually during study visits from 1996 to 2003. RESULTS: Among this population of Black and White women (mean baseline age = 45.6 years, SD = 2.7 years), all of whom were premenopausal at baseline, higher baseline leptin concentrations predicted longer stair climb, sit-to-rise, and 2-pound lift times and shorter forward reach distance (all p < .01). This relationship persisted after adjustment for age, BMI, percent skeletal muscle mass, race/ethnicity, economic strain, bodily pain, diabetes, knee osteoarthritis, and C-reactive protein. Baseline total adiponectin concentrations did not predict any mobility measures but did predict quadriceps strength; a 1 µg/mL higher adiponectin concentration was associated with 0.64 Nm lower quadriceps strength (p = .02). Resistin was not associated with any of the physical functioning performance measures. Change in the adipokines was not associated with physical functioning. CONCLUSION: In this population of middle-aged women, higher baseline leptin concentrations predicted poorer mobility-based functioning, whereas higher adiponectin concentrations predicted reduced quadriceps strength. These findings suggest that the relationship between the adipokines and physical functioning performance is independent of other known correlates of poor functioning.
BACKGROUND: Excess fat mass is a greater contributor to functional limitations than is reduced lean mass or the presence of obesity-related conditions. The impact of fat mass on physical functioning may be due to adipokines, adipose-derived proteins that have pro- or anti-inflammatory properties. METHODS: Serum samples from 1996 to 2003 that were assayed for leptin, adiponectin, and resistin were provided by 511 participants from the Michigan site of the Study of Women's Health Across the Nation. Physical functioning performance was assessed annually during study visits from 1996 to 2003. RESULTS: Among this population of Black and White women (mean baseline age = 45.6 years, SD = 2.7 years), all of whom were premenopausal at baseline, higher baseline leptin concentrations predicted longer stair climb, sit-to-rise, and 2-pound lift times and shorter forward reach distance (all p < .01). This relationship persisted after adjustment for age, BMI, percent skeletal muscle mass, race/ethnicity, economic strain, bodily pain, diabetes, knee osteoarthritis, and C-reactive protein. Baseline total adiponectin concentrations did not predict any mobility measures but did predict quadriceps strength; a 1 µg/mL higher adiponectin concentration was associated with 0.64 Nm lower quadriceps strength (p = .02). Resistin was not associated with any of the physical functioning performance measures. Change in the adipokines was not associated with physical functioning. CONCLUSION: In this population of middle-aged women, higher baseline leptin concentrations predicted poorer mobility-based functioning, whereas higher adiponectin concentrations predicted reduced quadriceps strength. These findings suggest that the relationship between the adipokines and physical functioning performance is independent of other known correlates of poor functioning.
Authors: J David Curb; Clementina D Ceria-Ulep; Beatriz L Rodriguez; John Grove; Jack Guralnik; Brad J Willcox; Tim A Donlon; Kamal H Masaki; Randi Chen Journal: J Am Geriatr Soc Date: 2006-05 Impact factor: 5.562
Authors: MaryFran Sowers; Mary L Jannausch; Melissa Gross; Carrie A Karvonen-Gutierrez; Riann M Palmieri; Mary Crutchfield; Kerry Richards-McCullough Journal: Am J Epidemiol Date: 2006-03-22 Impact factor: 4.897
Authors: MaryFran R Sowers; Mary Crutchfield; Kerry Richards; Margaret K Wilkin; Anna Furniss; Mary Jannausch; Daowen Zhang; Melissa Gross Journal: J Gerontol A Biol Sci Med Sci Date: 2005-04 Impact factor: 6.053
Authors: Brenda W J H Penninx; Stephen B Kritchevsky; Anne B Newman; Barbara J Nicklas; Eleanor M Simonsick; Susan Rubin; Michael Nevitt; Marjolein Visser; Tamara Harris; Marco Pahor Journal: J Am Geriatr Soc Date: 2004-07 Impact factor: 5.562
Authors: Carrie A Karvonen-Gutierrez; Siobán D Harlow; Jon Jacobson; Peter Mancuso; Yebin Jiang Journal: Ann Rheum Dis Date: 2013-04-10 Impact factor: 19.103
Authors: Sarah J B Snelling; Sylvette Bas; Gabor J Puskas; Stephanie G Dakin; Domizio Suva; Axel Finckh; Cem Gabay; Pierre Hoffmeyer; Andrew J Carr; Anne Lübbeke Journal: PLoS One Date: 2017-04-11 Impact factor: 3.240
Authors: Samar R El Khoudary; Gail Greendale; Sybil L Crawford; Nancy E Avis; Maria M Brooks; Rebecca C Thurston; Carrie Karvonen-Gutierrez; L Elaine Waetjen; Karen Matthews Journal: Menopause Date: 2019-10 Impact factor: 2.953
Authors: Sankar D Navaneethan; John P Kirwan; Erick M Remer; Erika Schneider; Bryan Addeman; Susana Arrigain; Ed Horwitz; Jeffrey C Fink; James P Lash; Charles A McKenzie; Mahboob Rahman; Panduranga S Rao; Jesse D Schold; Tariq Shafi; Jonathan J Taliercio; Raymond R Townsend; Harold I Feldman Journal: Am J Kidney Dis Date: 2020-08-13 Impact factor: 8.860